Skip to content

Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance

Food Anthocyanins and Flavanols as a Strategy for a Healthy Ageing: Cardiovascular Health and Cognitive Performance

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04348162
Acronym
POLYAGE
Enrollment
90
Registered
2020-04-16
Start date
2017-09-15
Completion date
2021-05-15
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Aging

Brief summary

The study examines the effect of cocoa flavanols, red-berries anthocyanins or a combination of both on markers of cardiovascular health and cognition.

Detailed description

The study examines the effect of cocoa flavanols, red-berries anthocyanins or a combination of both on markers of cardiovascular health and cognition. Healthy volunteers are recruited to participate in a parallel study (n 30 per group) for 10 to 12 weeks. Markers of cardiovascular health (FMD, markers of inflammation and fatty acid metabolism) and cognition (neuropsychological tests and plasma neurotrophins) are being measured before and after intervention.

Interventions

OTHERCocoa flavanols and berries anthocyanins

Effect of cocoa flavanols and berries anthocyanins on cardiovascular and cognitive health

Sponsors

Hospital Universitario 12 de Octubre
CollaboratorOTHER
National Research Council, Spain
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 50-85 * BMI 20-32 Kg/m2

Exclusion criteria

* Mini-mental state examination (MMSE) \< 28 * Systolic blood pressure (SBP) \>139 mmHg * Diastolic blood pressure (DBP) \> 89 mmHg * Total cholesterol \> 6.5 mmol/L

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline of flow-mediated vasodilatation (FMD) of the brachial arteryOver 6 minutes on day 0 and after10 weeksThe FMD of the brachial artery will be measured using an ultrasound collected at baseline and continuously for 60 seconds post-arm occlusion for 5 minutes. FMD will be expressed as percentage of variation between pre-and postischemic diameters

Secondary

MeasureTime frameDescription
Change from baseline STROOP score after 10 weeks interventionat inclusion and 10 weeks after interventionSTROOP tests attention and executive function. This test aims to evaluate the inhibition of an automated process such as reading by asking participants to name the color of color names written in a different color ink. For each participant SROOP results at inclusion will be compared with results after 10 weeks intervention
Change from baseline Tower of London score after 10 weeks interventionat inclusion and 10 weeks after interventionTower of London test consist of a three color game board that allows executive functioning evaluation by total time, time to first move and optimal moves change from participants inclusion to week 11.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026